
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
The CMII keeps track of exam volume, operating hours, types of use, and locations with imaging capacity. It provides information on the availability of staff, funding sources, ordering and referral procedures, and the use of tools that could facilitate appropriate imaging, system efficiency, and a reduction in wait lists.
To record current practises and developments in the supply, distribution, technical operations, and general clinical and research use of advanced imaging equipment across Canada, CADTH established the Canadian Medical Imaging Inventory (CMII). This data can be used to identify service gaps, forecast future demand, and guide capital planning and equipment replacement strategies.
Medical imaging is essential for identifying, tracking, and, occasionally, treating a wide range of diseases and conditions, from cancer to traumatic injury. It's important to keep track of where imaging capacity is as imaging technology develops.the following imaging modalities:CT,MRI,single-photon emission computed tomography,(SPECT),PET-CT,PET-MRI,SPECT-CT.
These six modalities were given priority to manage the project scope. The scope will be reassessed and expanded in future iterations, if possible.
Canada medical imaging market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Fujifilm Canada Inc. Launches A New Medical Systems Division To Market And Sell Its Diagnostic Imaging Solutions Nationally
The new division's sales structure is anticipated to significantly increase the commercialization of Fujifilm's cutting-edge diagnostic imaging systems and make the newest technologies accessible to Canadian hospitals, clinics, and healthcare providers.
Future plans for FUJIFILM Canada Inc. include bringing a broad range of diagnostic imaging systems to the Canadian market. . announced the launch of the new Medical Systems Division today.
Fujifilm DR solutions, built on a history of imaging, offer clinicians workflow efficiency while delivering exceptional image quality at a low dose.
The medical equipment from Fujifilm is adaptable to a range of clinical requirements. Furthermore, Fujifilm DR's sophisticated image processing, which is intended to enhance image quality and dose efficiency, makes it suitable for special patient needs, such as paediatrics.
A wide range of DR and women's health solutions, including a number of portable X-ray systems, a full DR suite, a new generation of flat panel detectors, and a full field digital mammography solution with digital breast tomosynthesis, will be made available in the near future by FUJIFILM Canada Inc., Medical Systems Division.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |